Pfam Domains GO Terms
| fn3 |
| interleukin-7 receptor activity |
| negative regulation of T cell mediated cytotoxicity |
| positive regulation of T cell differentiation in thymus |
| lymph node development |
| negative regulation of leukocyte mediated cytotoxicity |
| negative regulation of T cell apoptotic process |
| negative regulation of T cell mediated immunity |
| interleukin-7-mediated signaling pathway |
| negative regulation of cell killing |
| regulation of T cell differentiation in thymus |
| negative regulation of lymphocyte apoptotic process |
| cellular response to interleukin-7 |
| response to interleukin-7 |
| regulation of T cell apoptotic process |
| regulation of T cell mediated cytotoxicity |
| negative regulation of lymphocyte mediated immunity |
| negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| B cell proliferation |
| negative regulation of adaptive immune response |
| negative regulation of leukocyte apoptotic process |
| cytokine receptor activity |
| negative regulation of leukocyte mediated immunity |
| regulation of lymphocyte apoptotic process |
| clathrin-coated vesicle membrane |
| regulation of T cell mediated immunity |
| regulation of leukocyte mediated cytotoxicity |
| regulation of leukocyte apoptotic process |
| positive regulation of T cell differentiation |
| lymphocyte proliferation |
| mononuclear cell proliferation |
| positive regulation of receptor signaling pathway via STAT |
| positive regulation of lymphocyte differentiation |
| leukocyte proliferation |
| regulation of cell killing |
| regulation of DNA recombination |
| negative regulation of immune effector process |
| regulation of receptor signaling pathway via STAT |
| T cell differentiation |
| regulation of T cell differentiation |
| antigen binding |
| regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| positive regulation of leukocyte differentiation |
| negative regulation of immune response |
| regulation of lymphocyte mediated immunity |
| B cell activation |
| immunoglobulin production |
| regulation of adaptive immune response |
| regulation of lymphocyte differentiation |
| production of molecular mediator of immune response |
| regulation of cell size |
| positive regulation of hemopoiesis |
| homeostasis of number of cells |
| positive regulation of T cell activation |
| regulation of leukocyte mediated immunity |
| positive regulation of leukocyte cell-cell adhesion |
| T cell activation |
| lymphocyte differentiation |
| positive regulation of cell-cell adhesion |
| regulation of leukocyte differentiation |
| regulation of leukocyte cell-cell adhesion |
| regulation of T cell activation |
| leukocyte differentiation |
| regulation of DNA metabolic process |
| positive regulation of lymphocyte activation |
| regulation of cellular component size |
| lymphocyte activation |
| external side of plasma membrane |
| regulation of cell-cell adhesion |
| positive regulation of cell adhesion |
| positive regulation of leukocyte activation |
| positive regulation of cell activation |
| negative regulation of immune system process |
| regulation of hemopoiesis |
| regulation of immune effector process |
| regulation of anatomical structure size |
| regulation of lymphocyte activation |
| cell population proliferation |
| hemopoiesis |
| regulation of leukocyte activation |
| hematopoietic or lymphoid organ development |
| regulation of cell activation |
| immune system development |
| cytokine-mediated signaling pathway |
| regulation of cell adhesion |
| cell morphogenesis |
| cellular component morphogenesis |
| membrane organization |
| negative regulation of apoptotic process |
| negative regulation of programmed cell death |
| positive regulation of cell population proliferation |
| leukocyte activation |
| positive regulation of cell differentiation |
| negative regulation of cell death |
| cellular response to cytokine stimulus |
| cell activation |
| response to cytokine |
| positive regulation of immune system process |
| regulation of immune response |
| positive regulation of developmental process |
| regulation of apoptotic process |
| regulation of programmed cell death |
| regulation of cell population proliferation |
| negative regulation of response to stimulus |
| homeostatic process |
| regulation of immune system process |
| positive regulation of signal transduction |
| regulation of cell death |
| positive regulation of multicellular organismal process |
| regulation of cell differentiation |
| positive regulation of cell communication |
| positive regulation of signaling |
| immune response |
| extracellular region |
| positive regulation of gene expression |
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
| Screen | Score |
|---|---|
| JQ1 0.8μM R08 exp435 | -1.71 |
| Geldanamycin 0.015 to 0.025μM on day4 R07 exp316 | 1.79 |
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 0/28 |
| blood | 0/28 |
| bone | 0/26 |
| breast | 0/33 |
| central nervous system | 0/56 |
| cervix | 0/4 |
| colorectal | 0/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 0/16 |
| kidney | 0/21 |
| liver | 0/20 |
| lung | 0/75 |
| lymphocyte | 0/16 |
| ovary | 0/26 |
| pancreas | 0/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 0/15 |
| prostate | 0/1 |
| skin | 0/24 |
| soft tissue | 0/9 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 0/29 |
| uterus | 0/5 |
Expression Distribution